Ron McMaster is an experienced professional in the biopharmaceutical industry, currently serving as the Director of Global MS&T Drug Substance Commercialization at Vaxcyte since May 2025. Previously, Ron held the position of Director of Tech Transfer at Merck for a brief period in early 2025. Prior to that, Ron was the Director of Product Development and Manufacturing at HilleVax from January 2023 to December 2024. Ron's experience also includes a role in Process Technology at BioSpectra, Inc. and extensive tenure at Sanofi, where roles included Director of Bacterial Vaccine Manufacturing and Director of Manufacturing Science and Technologies. Ron McMaster earned an M.B.A. in Technology Management from the University of Phoenix and a degree from Lehigh University.
This person is not in any teams
This person is not in any offices